Search results

Found 245 pages
AUTHOR: Katrina Megget

Results per page

10 20 50 100

Sort by

Relevance Date

2 Dec 2009:

Roche’s diabetes drug tops rival Januvia

Roche and Ipsen’s investigational type 2 diabetes drug taspoglutide has inched its way ahead of rival Merck’s Januvia, according to late stage studies. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/roches_diabetes_drug_tops_rival_januvia_984174

4 Jan 2011:

Janssen’s Invega gets green light

Janssen-Cilag International has been given the thumbs up by the European Commission for its antipsychotic drug Invega (paliperidone ER) – the first treatment for schizoaffective disorder in Europe. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/janssens_invega_gets_green_light_979838

17 Dec 2010:

Brilinta decision delayed again

The anticipated positive decision for AstraZeneca’s anticlotting drug Brilinta (ticagrelor) in the USA has not materialised after regulators announced they wanted more information.  - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/brilinta_decision_delayed_again_981297

9 Sep 2009:

Lilly in dock over improper marketing

Eli Lilly is the new drug giant to be raked over hot coals for improper marketing of its drugs. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/lilly_in_dock_over_improper_marketing_983681

17 Nov 2014:

US tax changes don't scare Pfizer

Drugs giant Pfizer has not ruled out a merger abroad to take advantage of low tax rates, despite the US clampdown on the tax inversion loophole. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/us_tax_changes_dont_scare_pfizer_1002776

6 May 2015:

Undecided who to vote for in the UK General Election?

Tomorrow is the big day – 7 May; UK General Election day.  - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/undecided_who_to_vote_for_in_the_uk_general_election_971378

7 Oct 2008:

Remicade effective in treating Crohn’s

Johnson & Johnson’s Remicade (infliximab) has been shown to control Crohn’s disease more effectively than standard immunomodulator azathioprine, the company says. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/remicade_effective_in_treating_crohns_986658

16 Sep 2008:

Biovitrum takes on Amgen products

Pharmaceutical company Biovitrum has taken on three of Amgen’s biologics products in a deal worth more than $130 million. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/biovitrum_takes_on_amgen_products_987853

13 Oct 2008:

Seroquel XR gets approved in the USA

The US Food and Drug Administration has given the green light to AstraZeneca’s bipolar extended release treatment Seroquel XR (quetiapine fumarate). - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/seroquel_xr_gets_approved_in_the_usa_986614

7 Oct 2009:

£3bn windfall predicted for GSK

Analysts are predicting UK pharma giant GlaxoSmithKline will be hitting a £3 billion jackpot by the end of the year following demand for its swine flu vaccine Pandemrix. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/3bn_windfall_predicted_for_gsk_984494